- $1.03tn
- $1.07tn
- $65.18bn
Brief: Lilly Announces Three Acquisitions To Build Infectious Disease Portfolio
Lilly climbs after buying three vaccine developers
Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push (updated)
Lilly to acquire three vaccine developers for $4 billion
Brief: Lilly Agrees To Buy Trio Of Vaccine Developers - WSJ
China's commerce ministry holds meeting with foreign pharmaceutical firms
European medicines regulator recommends approval for Novo's Wegovy pill (updated)
European medicines regulator recommends approval for Novo's Wegovy pill
U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday
U.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
Lilly gains after data for next-generation weight loss drug
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight (updated)
U.S. STOCKS ON THE MOVE-Osisko Development, Walmart, Eli Lilly
Lilly gains after data for next-generation weight loss drug
Patients on Lilly's next-gen obesity drug lost 28% of body weight, company says
Brief: Eli Lilly Retatrutide 12 Mg Achieved 30.3% Average Weight Loss At 104 Weeks In Extension
Focus: Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say